ISSN: 2155-9872
Journal of Analytical & Bioanalytical Techniques
天美传媒 Access
Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 天美传媒 Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
天美传媒 Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Citations : 6413
Indexed In
- CAS Source Index (CASSI)
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Academic Journals Database
- 天美传媒 J Gate
- Genamics JournalSeek
- JournalTOCs
- ResearchBible
- China National Knowledge Infrastructure (CNKI)
- Ulrich's Periodicals Directory
- Electronic Journals Library
- RefSeek
- Directory of Research Journal Indexing (DRJI)
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Scholarsteer
- SWB online catalog
- Virtual Library of Biology (vifabio)
- Publons
- Euro Pub
- ICMJE
Useful Links
Related Subjects
Share This Page
Platform Size Exclusion Chromatography (SEC) method development for a broad range of monoclonal antibodies
Joint Event on 18th International Conference on World Analytical Chemistry & Mass Spectrometry & World HPLC, Separation Techniques & Pharmacovigilance
Isil Yasa, Vandana Chandrasekar, Michael Adamo, Amit Katiyar, Tapan Das and Ryan Knihtila
Bristol-Myers Squibb, USA
Posters & Accepted Abstracts: J Anal Bioanal Tech
DOI:
Abstract
Understanding of size heterogeneity in biotherapeutic proteins is essential since it is one of the Critical Quality Attributes (CQA) due to its impact on safety and efficacy. The size heterogeneity covers the product related species/impurities that includes fragments, monomers and aggregates. Size exclusion chromatography (SEC) has been widely used to separate aggregates, monomer and fragments of monoclonal antibodies (mAbs) that might form during manufacturing, storage and shipping. The progress in biologics pipeline and the urgency to reach first-in-human (FIH) has provided an opportunity to develop a generic method that can serve as a platform method for monoclonal antibodies. This study describes platform SEC method development for monoclonal antibodies using commercially available highperformance liquid chromatography (HPLC) and ultra-performance liquid chromatography (UPLC) SEC columns. For this purpose, several antibodies covering a broad range of isoelectric points (pI) and hydrophobicity were analyzed. Initial comparison was performed using six different mAbs to understand the impact of mobile phase and organics on separation of aggregates and fragments.Biography
E-mail: isil.yasa@bms.com
